Brian Troy Frederick
26Patents
12h-index
30Co-inventors
77Inventor score
Filing activity: Jan 30, 2008 → Sep 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9624268B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 26 | Active |
| US9822157B2 | Hepcidin analogues and uses thereof | Human Necessities | 25 | Active |
| US9714270B2 | a4B7 integrin thioether peptide antagonists | Human Necessities | 24 | Active |
| US10030061B2 | Hepcidin analogues and uses thereof | Human Necessities | 21 | Active |
| US10023614B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 19 | Active |
| US10035824B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 19 | Active |
| US10059744B2 | α4β7 thioether peptide dimer antagonists | Human Necessities | 19 | Active |
| US10196424B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 17 | Active |
| US10442846B2 | Hepcidin analogues and uses thereof | Human Necessities | 15 | Active |
| US10501515B2 | Hepcidin analogues and uses thereof | Human Necessities | 15 | Active |
| US10787490B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Human Necessities | 13 | Active |
| US10278957B2 | Opioid agonist peptides and uses thereof | Chemistry; Metallurgy | 13 | Active |
| US10626146B2 | α4β7 thioether peptide dimer antagonists | Human Necessities | 12 | Active |
| US11041000B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Chemistry; Metallurgy | 8 | Active |
| US10941183B2 | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases | Physics | 8 | Active |
| US10729676B2 | Opioid agonist peptides and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US11472842B2 | Analogues of hepcidin mimetics with improved in vivo half lives | Human Necessities | 4 | Active |
| US8106154B2 | Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules | Chemistry; Metallurgy | 3 | Active |
| US11753443B2 | Conjugated hepcidin mimetics | Human Necessities | 2 | Active |
| US11807674B2 | Hepcidin analogues and uses thereof | Human Necessities | 2 | Active |
| US12269856B2 | Hepcidin analogues and uses thereof | Human Necessities | 0 | Active |
| US11840581B2 | α4β7 thioether peptide dimer antagonists | Human Necessities | 0 | Active |
| US11845808B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Human Necessities | 0 | Active |
| US12018057B2 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | Human Necessities | 0 | Active |
| US12234300B2 | Conjugated hepcidin mimetics | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.